NRD
INSP icon

Nebula Research & Development’s Inspire Medical Systems INSP Stock Holding History

Nebula Research & Development’s Portfolio INSP Stock Details INSP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-13,522
Closed -$1.75M – 428
2025
Q2 		$1.75M Sell
13,522
-1,032
-7% -$150K 0.15% 223
2025
Q1 		$2.32M Buy
14,554
+11,596
+392% +$2.1M 0.21% 128
2024
Q4 		$548K Buy
+2,958
New +$574K 0.06% 521
2023
Q4 		– Sell
-2,104
Closed -$418K – 757
2023
Q3 		$418K Buy
2,104
+298
+17% +$75.2K 0.22% 179
2023
Q2 		$586K Buy
+1,806
New +$516K 0.44% 103

Other funds holding INSP

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Nebula Research & Development's INSP Position: Q3 2025 in Review

Nebula Research & Development sold out of Inspire Medical Systems (INSP) in Q3 2025, closing a stake of 13,522 shares — an estimated $1.75M sold.

Nebula Research & Development first reported a position in INSP in Q2 2023 and held it in 5 quarters. The position peaked at $2.32M in Q1 2025. 325 funds tracked by Wall St. Rank hold INSP as of Q3 2025.

  • Nebula Research & Development reported no remaining Inspire Medical Systems position as of Q3 2025 after selling out during the quarter.
  • Nebula Research & Development sold 13,522 Inspire Medical Systems shares in Q3 2025, an estimated $1.75M.
  • Nebula Research & Development first reported a position in Inspire Medical Systems in Q2 2023 and held it in 5 quarters.
  • Nebula Research & Development's Inspire Medical Systems position peaked at $2.32M in Q1 2025.
  • 325 funds tracked by Wall St. Rank held Inspire Medical Systems as of Q3 2025.

Based on Nebula Research & Development's 13F filing for Q3 2025.